Pandanus Associates Inc. bought 359,500 shares of BEAUTYFARM MED (02373) on the SEHK open market at an average of HKD 19.3369 per share on September 21, 2026, involving about HKD 6.95 million. The transaction is an on-exchange active trade, i.e. a direct dealing in the secondary market.
Prior to the acquisition, Pandanus Associates Inc.'s long position in BEAUTYFARM MED was 14.92 million shares, representing 5.93%; following the acquisition, the holding changed to 15.28 million shares, with the long position ratio rising to 6.07%.